Navigation Links
Diagenode to Provide Cutting Edge Library Preparation Products for MGI in USA, Europe and Asia Pacific
Date:3/5/2020

Diagenode, a leading global provider of complete solutions for sample preparation and epigenetics research, and MGI Tech (MGI), a subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement for Diagenode’s innovative NGS library preparation product line in the United States, Europe and Asia Pacific.

Under the terms of the non-exclusive agreement, the two companies have made Diagenode’s newest D-Plex Library Preparation products available on the MGI platform. MGI and Diagenode will market and promote Diagenode’s solutions for advanced epigenetic discoveries including the innovative D-Plex small RNA-sequencing technology, specifically formatted to work with MGI’s DNBSEQ™ sequencers using the appropriate MGI-compatible products.

“This agreement brings together our best-in-class and unique library preparation products and MGI’s high-quality cost-effective PCR-free sequencing solution, creating a combined platform to embrace the rapidly expanding markets in USA, Asia Pacific and Europe,” said Didier Allaer, CEO and founder of Diagenode. “This initiative brings premium epigenetics products to MGI’s customers, allowing them to experience exceptional performance and new discoveries.”

“This important collaboration leverages the strengths of both companies and provides an opportunity to extend our capabilities and advanced sequencing technology for our customers working in cancer, neurology, autoimmune disease and other genomic applications,” said Duncan Yu, president of MGI. “Demand is growing for MGI’s DNBSEQ™ platform with its high accuracy, affordability and applications within the marketplace. We look forward to a continued expansion of our offerings with leading products like the Diagenode D-Plex small RNA-sequencing solution specifically optimized with our platform.”

About MGI
MGI, a subsidiary of BGI Group, is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI produces sequencing instruments, reagents, equipment and related products to support life science research, agriculture, medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include sequencing, mass spectrometry, medical imaging and laboratory automation. Providing real-time, comprehensive, life-long solutions, its vision is to enable effective and affordable healthcare solutions for all.

About Diagenode Inc Corporation
Diagenode is a leading provider of complete solutions for epigenetics research and sample preparation. The company has developed both shearing solutions for a number of applications as well as a comprehensive approach to gain new insights into epigenetics studies. The company offers innovative DNA and chromatin shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, ChIP, and ChIP-seq workflows. The company’s latest innovations include the industry’s most validated ChIP antibodies, D-Plex RNA sequencing with UMIs, and epigenetics assay services including scATAC-seq. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.

Read the full story at https://www.prweb.com/releases/diagenode_to_provide_cutting_edge_library_preparation_products_for_mgi_in_usa_europe_and_asia_pacific/prweb16957809.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Diagenode Announces Acquisition of Service Provider NXT-Dx to Complement Epigenetics Assay Services
2. Diagenode Gains Exclusive Rights to New ChIPmentation Technology for Chromatin Immunoprecipitation with High Throughput Sequencing
3. Diagenode to Offer Single-Cell ATAC-Seq Services Featuring Bio-Rad’s Droplet Digital PCR Technology
4. Clinilabs Welcomes Anesthesiologist Dr. Admir Hadzic Who Will Provide CSF/cCSF Capabilities For Clinilabs
5. Genome sequencing provides unprecedented insight into causes of pneumococcal disease
6. New robotic instruments to provide real-time data on Gulf of Maine red tide
7. US urban trees store carbon, provide billions in economic value
8. Study provides insight into nesting behavior of dinosaurs
9. Schools should provide students with daily physical activity, IOM recommends
10. Schools should provide opportunities for 60 minutes of daily physical activity to all students
11. New research shows that potatoes provide one of the best nutritional values per penny
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2020)... , ... February 28, 2020 , ... Meridian Clinical ... 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is ... for the Best Clinical Trial Network award. These nominations were the result of two ...
(Date:2/28/2020)... ... February 27, 2020 , ... Regen Suppliers is now offering the top ... thread lift products are not only one of the only FDA Cleared options ... procedures are increasing exponentially in popularity, as they represent an excellent nonoperative method of ...
(Date:2/26/2020)... ... 25, 2020 , ... Renowned eye surgical practice led by Steven J. Dell, ... offer the FDA-approved, post-surgical, corrective Light Adjustable Lens (LAL) by RxSight™. Since offering this ... Dell Laser Consultants is also currently involved in the latest LAL FDA study. , ...
Breaking Biology News(10 mins):
(Date:4/1/2020)... ... March 30, 2020 , ... A joint venture between mobile ... earlier this year to bring telehealth to various government agencies, has now focused ... officials are currently?awaiting an Emergency Use Authorization (EUA) waiver from the FDA?to?perform?AI?testing in ...
(Date:4/1/2020)... ... March 31, 2020 , ... Bedoukian Research, Inc. ... a Joint Development Agreement that builds on each company’s expertise in developing efficient ... in the supply of high-quality insect pheromones as well as flavors and fragrances. ...
(Date:3/19/2020)... ... March 17, 2020 , ... ... collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) to ... and other solid tumor indications. The collaboration will leverage RoosterBio’s human mesenchymal ...
(Date:3/12/2020)... ... March 12, 2020 , ... With the beginning ... increases the business investment in Europe by inaugurating a new scientific facility for ... of the new Nanoscience Center Europe took place Tuesday, February 18, 2020, gathering ...
Breaking Biology Technology: